ScinoPharm Taiwan Ltd
TWSE:1789

Watchlist Manager
ScinoPharm Taiwan Ltd Logo
ScinoPharm Taiwan Ltd
TWSE:1789
Watchlist
Price: 22.6 TWD 1.12%
Market Cap: 17.9B TWD
Have any thoughts about
ScinoPharm Taiwan Ltd?
Write Note

Wall Street
Price Targets

Price Targets Summary
ScinoPharm Taiwan Ltd

There are no price targets for ScinoPharm Taiwan Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
ScinoPharm Taiwan Ltd Competitors:
Price Targets
4554
Fuji Pharma Co Ltd
46% Upside
000999
China Resources Sanjiu Medical & Pharmaceutical Co Ltd
21% Upside
KILITCH
Kilitch Drugs (India) Ltd
47% Upside
BMY
Bristol-Myers Squibb Co
5% Upside
1177
Sino Biopharmaceutical Ltd
44% Upside
CONCORDBIO
Concord Biotech Ltd
6% Downside

Revenue
Forecast

Revenue Estimate
ScinoPharm Taiwan Ltd

For the last 8 years the compound annual growth rate for ScinoPharm Taiwan Ltd's revenue is -3%. The projected CAGR for the next 1 year is -5%.

-3%
Past Growth
-5%
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Operating Income
Forecast

Operating Income Estimate
ScinoPharm Taiwan Ltd

For the last 8 years the compound annual growth rate for ScinoPharm Taiwan Ltd's operating income is -10%. The projected CAGR for the next 1 year is -33%.

-10%
Past Growth
-33%
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Net Income
Forecast

Net Income Estimate
ScinoPharm Taiwan Ltd

For the last 8 years the compound annual growth rate for ScinoPharm Taiwan Ltd's net income is -9%. The projected CAGR for the next 1 year is -27%.

-9%
Past Growth
-27%
Estimated Growth
Estimates Accuracy
-20%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ScinoPharm Taiwan Ltd's stock price target?
Not Available

ScinoPharm Taiwan Ltd doesn't have any price targets made by Wall Street professionals.

What is ScinoPharm Taiwan Ltd's Revenue forecast?
Projected CAGR
-5%

For the last 8 years the compound annual growth rate for ScinoPharm Taiwan Ltd's revenue is -3%. The projected CAGR for the next 1 year is -5%.

What is ScinoPharm Taiwan Ltd's Operating Income forecast?
Projected CAGR
-33%

For the last 8 years the compound annual growth rate for ScinoPharm Taiwan Ltd's operating income is -10%. The projected CAGR for the next 1 year is -33%.

What is ScinoPharm Taiwan Ltd's Net Income forecast?
Projected CAGR
-27%

For the last 8 years the compound annual growth rate for ScinoPharm Taiwan Ltd's net income is -9%. The projected CAGR for the next 1 year is -27%.

Back to Top